SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-002687
Filing Date
2017-03-21
Accepted
2017-03-21 16:12:32
Documents
105
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1409998
2 image_001.jpg GRAPHIC 21199
3 image_002.jpg GRAPHIC 8365
4 ex21-1.htm EX-21.1 7135
5 ex23-1.htm EX-23.1 4693
6 ex31-1.htm EX-31.1 19322
7 ex31-2.htm EX-32.2 19060
8 ex32-1.htm EX-32.1 9275
9 ex32-2.htm EX-32.2 8828
  Complete submission text file 0001493152-17-002687.txt   7403068

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE immy-20161231.xml EX-101.INS 1223959
11 XBRL SCHEMA FILE immy-20161231.xsd EX-101.SCH 80308
12 XBRL CALCULATION FILE immy-20161231_cal.xml EX-101.CAL 121773
13 XBRL DEFINITION FILE immy-20161231_def.xml EX-101.DEF 337055
14 XBRL LABEL FILE immy-20161231_lab.xml EX-101.LAB 606623
15 XBRL PRESENTATION FILE immy-20161231_pre.xml EX-101.PRE 487040
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 17704329
SIC: 2834 Pharmaceutical Preparations